StockNews.com upgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a hold rating to a buy rating in a research note released on Friday morning. Other equities analysts have also recently issued research reports about the stock. Citigroup raised their target price on shares of Charles River Laboratories International from $215.00 to […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) shares dropped 4.1% on Thursday . The company traded as low as $220.44 and last traded at $223.00. Approximately 273,632 shares traded hands during trading, a decline of 50% from the average daily volume of 546,376 shares. The stock had previously closed at $232.56. Analysts […]
Charles River Laboratories International (NYSE:CRL) Downgraded by Guggenheim to Neutral themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Robert W Baird Raises Charles River Laboratories International (NYSE:CRL) Price Target to $268 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Charles River Laboratories International (NYSE:CRL – Get Free Report) had its price objective raised by equities researchers at UBS Group from $270.00 to $290.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has a “buy” rating on the medical research company’s stock. UBS Group’s price target would suggest a potential […]